The core claim is largely accurate on out-of-pocket costs for employed women under employer-sponsored insurance, but the framing as pure systemic discrimination or “paying more for lesser quality” is overstated and incomplete. Higher utilization by women (driven by biology, reproductive health, screening guidelines, and behavior) explains most of the difference. U.S. women also live longer than U.S. men, and the international comparisons mix system-level U.S. problems with sex-specific ones.
The Cost Numbers
A 2023 Deloitte actuarial analysis of claims data for >16 million people with employer-sponsored coverage (2017–2022) found employed women ages 19–64 had roughly
$15–15.4 billion more in annual out-of-pocket costs than men. For single coverage, that averaged about
$266 more per year (≈18%) after excluding maternity-related claims. Maternity accounted for only a small portion of the gap (removing it reduced the difference by <2 percentage points). Women hit deductibles and out-of-pocket maximums more often because they use more services.
Related data (e.g., GoodRx on prescriptions) show women spending more out-of-pocket on drugs as well—driven by higher fill rates for conditions more common in women (migraine, anxiety/depression meds, certain autoimmune-related treatments, contraceptives, menopause care, etc.).
These figures are real and do not stem primarily from higher premiums (ACA rules generally prohibit sex-based premium differences for employer plans). Benefit design (deductibles, cost-sharing on common women’s services like imaging or gynecologic care) interacts with higher utilization to produce the gap. Closing the actuarial-value difference would be relatively cheap for employers (~$12 per employee/year in one estimate).
Why Women Use More Care
Women visit providers more often and generate higher claims even after excluding pregnancy. Key drivers include:
- Biology and guidelines: Routine gynecologic care, earlier/more frequent recommended screenings in some areas, menopause transitions, higher rates of certain autoimmune conditions, migraines, and other conditions that prompt more visits/prescriptions. Breast imaging is relatively costly compared with some male-specific screens.
- Behavior: Women are more likely to seek preventive and primary care; men are far more likely to go years between visits.
- Reproductive and sex-specific needs that have no direct male equivalent in volume.
This is not primarily “bias causing over-use.” Sex differences in disease prevalence, immune function (women generally have stronger immune responses, which helps against infection/cancer but raises autoimmune risk), hormones, and anatomy produce different utilization patterns. Men face higher rates of certain high-cost acute events later (heart disease, some cancers) and higher mortality from injuries, suicide, overdoses, etc.
Outcomes and the “Lesser Quality / Avoidable Deaths” Claim
The Commonwealth Fund brief correctly notes U.S. women have the highest rate of
avoidable (preventable/treatable) deaths among the high-income countries examined (~270 per 100,000 in 2021 data) and relatively low life expectancy
for women compared with peer countries (~80 years). U.S. healthcare overall underperforms on many access, primary-care, and affordability metrics versus peer nations that have universal coverage systems. Racial/ethnic disparities within the U.S. are also real.
However:
- U.S. women still substantially outlive U.S. men. Recent CDC data show female life expectancy around 81+ years vs. male ~76–77 (gap ~5 years; it widened during COVID and the overdose crisis but remains large). Men die earlier from heart disease, unintentional injuries/poisonings, suicide, homicide, and other causes at higher rates.
- International rankings for U.S. women reflect the same system-wide issues that also produce poor rankings for U.S. men (high costs, fragmentation, lifestyle factors, violence, etc.). Framing it mainly as a gender gap relative to men within the U.S. is selective.
- Women report higher rates of certain chronic conditions and mental-health needs in surveys, and there is documented evidence of dismissal or psychologizing of some women’s symptoms (pain, autoimmune, etc.). Counter-examples and bidirectional issues also exist (men’s mental health is under-diagnosed in different ways; some conditions present differently by sex and research historically lagged for both).
The mental-health dismissal points and the Lindsay Clancy case discussion in the thread are separate topics. Provider quality failures occur for both sexes; they do not uniquely prove a systemic “women pay more for worse care” story across the board.
Bottom Line
Women with employer coverage do pay more out-of-pocket on average because they use more covered services, even after maternity is removed. That is a measurable cost difference interacting with typical plan design. It is not primarily unexplained discrimination or evidence that women receive systematically inferior care relative to men in the U.S. Biological sex differences, screening guidelines, reproductive physiology, and care-seeking behavior drive most of the utilization gap. Broader U.S. healthcare cost/access problems affect both sexes and show up in international comparisons for women (and men). Treating the numbers as proof of a one-sided “pink tax” on care quality oversimplifies the data.
Can you debunk? https://justplainpolitics.com/threads/us-women-are-paying-billions-more-for-healthca
grok.com
commonwealthfund.org
World Economic Forum
